SanBio Co., Ltd.

Not Rated
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3336750009
JPY
2,237.00
-18 (-0.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
SanBio Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jan'26
Jan'25
Jan'24
Jan'23
Jan'22
Jan'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-4,291.00
-3,010.00
-2,542.00
-4,697.00
-4,560.00
-3,211.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-132.00
-91.00
-361.00
504.00
30.00
455.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-3,805.00
-3,616.00
-4,778.00
-7,451.00
-6,570.00
-5,272.00
Cash Flow from Investing Activities
-231.00
-4.00
-19.00
-10.00
-66.00
4,180.00
Cash Flow from Financing Activities
16,007.00
2,104.00
2,383.00
9,463.00
-1,471.00
0.00
Net Cash Inflow / Outflow
11,962.00
-1,536.00
-2,285.00
2,118.00
-7,923.00
-1,165.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-8.00
-20.00
128.00
116.00
185.00
-73.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of SanBio Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-4291.743
1933
-6,224.00
-322.02%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-132.475
770
-902.00
-117.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-3805.485
4429
-8,234.00
-185.92%
Cash Flow from Investing Activities
-231.044
-3540
3,309.00
93.47%
Cash Flow from Financing Activities
16007.285
-1571
17,578.00
1118.92%
Net Cash Inflow / Outflow
11962.142
-378
12,340.00
3264.59%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-8.614
304
-312.00
-102.83%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jan'26
stock-summary

YoY Growth in year ended Jan 2026 is -5.22% vs 24.31% in Jan 2025

Jan'26
Jan'25
Change(%)
Cash Flow from Operating Activities
-3,805.49
-3,616.71
-5.22%